$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How long is the resistance period to cabozantinib?
2026-02-01 22:25:32
Check Details
What are the consequences of stopping cabozantinib?
2026-02-01 22:25:32
Check Details
Analysis of the working principle of cabozantinib in targeted therapy
2026-02-01 22:25:32
Check Details
Is cabozantinib effective alone in treating liver cancer?
2026-02-01 22:25:32
Check Details
Complete medication guide for Serpatinib
2026-02-01 22:25:32
Check Details
Generic versions of serpotinib: a new cost-effective treatment option
2026-02-01 22:25:32
Check Details
Resistance challenges and countermeasures to serpatinib
2026-02-01 22:25:32
Check Details
Strategies and hopes for dealing with resistance to serpatinib
2026-02-01 22:25:32
Check Details
Durable therapeutic efficacy of serpotinib in RET-mutant thyroid cancer
2026-02-01 22:25:32
Check Details
How does ensidipine accurately attack IDH2 mutations in AML?
2026-02-01 22:25:32
Check Details
Ensidipine Dosage Guide: Usage, Dosage and Precautions
2026-02-01 22:25:32
Check Details
How can ensidipine revolutionize acute myeloid leukemia treatment?
2026-02-01 22:25:32
Check Details
1
2
...
996
997
998
999
1000
1001
1002
...
10238
10239
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure
2
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
3
Vosoritide Slowing Effect: Not Always Resistance—Check Dose, Adherence, Epiphyses
4
Ramosetron ODT for IBS-D: Gender-Based Dosing and Treatment Review
5
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
6
Acoramidis for ATTR-CM: TTR Stabilizer to Reduce CV Death and Hospitalization
7
Vosoritide Storage and Reconstitution: Refrigerate, 90-Day Room Temp, Use Within 3 Hours
8
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
9
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
10
Vosoritide Side Effects and Pre-Injection Food/Fluid: Injection-Site Reactions, Transient Hypotension
11
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
12
Pretomanid Mechanism and BPaL Use in Drug-Resistant TB